Status: Bibliographieeintrag
Standort: ---
Exemplare:
---
| |  Online-Ressource |
|---|
| Verfasst von: | Zhao, Jemmy [VerfasserIn]  |
|---|
| | Stephan-Falkenau, Susann [VerfasserIn] |
|---|
| | Schuler, Markus [VerfasserIn] |
|---|
| | Arndt, Börge [VerfasserIn] |
|---|
| Titel: | Management of locally advanced or metastatic combined hepatocellular cholangiocarcinoma |
|---|
| Verf.angabe: | Jemmy Zhao, Susann Stephan-Falkenau, Markus Schuler and Börge Arndt |
|---|
| E-Jahr: | 2023 |
|---|
| Jahr: | 3 February 2023 |
|---|
| Umfang: | 15 S. |
|---|
| Fussnoten: | Gesehen am 20.03.2023 |
|---|
| Titel Quelle: | Enthalten in: Cancers |
|---|
| Ort Quelle: | Basel : MDPI, 2009 |
|---|
| Jahr Quelle: | 2023 |
|---|
| Band/Heft Quelle: | 15(2023), 3 vom: Feb., Artikel-ID 988, Seite 1-15 |
|---|
| ISSN Quelle: | 2072-6694 |
|---|
| Abstract: | Combined hepatocellular cholangiocarcinoma (cHCC-CC) is a rare primary liver malignancy that comprises features of hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). Due to the rarity of this tumor, the treatment of choice has not yet been defined. For resectable disease, liver resection is the mainstay treatment. However, most patients relapse or display advanced disease and were not surgical candidates. Although the majority of patients are either primarily or secondarily treated in palliative intent, no guideline recommendations or prospective trial reports exist to allow reliable evaluation of debated treatment options. We review different locoregional or medical treatment options for advanced combined hepatocellular cholangiocarcinoma (cHCC-CC) in the neoadjuvant, adjuvant, or palliative setting and discuss the possibility of predictive biomarker-guided therapeutic options. |
|---|
| DOI: | doi:10.3390/cancers15030988 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.3390/cancers15030988 |
|---|
| | Volltext: https://www.mdpi.com/2072-6694/15/3/988 |
|---|
| | DOI: https://doi.org/10.3390/cancers15030988 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | adjuvant treatment |
|---|
| | chemotherapy |
|---|
| | combined hepatocellular cholangiocarcinoma (cHCC-CC) |
|---|
| | locoregional treatment |
|---|
| | neoadjuvant treatment |
|---|
| | palliative treatment |
|---|
| | sorafenib |
|---|
| K10plus-PPN: | 1839553693 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Management of locally advanced or metastatic combined hepatocellular cholangiocarcinoma / Zhao, Jemmy [VerfasserIn]; 3 February 2023 (Online-Ressource)
69053223
